- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-Risk Prostate Cancer in South Africa
Total 499 results
-
Medical University of South CarolinaTerminated
-
Medical University of South CarolinaWithdrawnProstate CancerUnited States
-
University of South CarolinaUnited States Department of DefenseCompleted
-
Medical University of South CarolinaWithdrawn
-
Medical University of South CarolinaCompleted
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
Royal North Shore HospitalCompleted
-
St George Hospital, AustraliaRecruiting
-
Royal North Shore HospitalUniversity of SydneyCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Biotech Equity Partners Pty LtdUnknownProstate CancerAustralia
-
Royal North Shore HospitalWithdrawn
-
Progen PharmaceuticalsAventis Pharmaceuticals; Northern Sydney and Central Coast Area Health ServiceCompleted
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Southwest Oncology GroupCompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerProstate CancerUnited States, South Africa
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
SanofiCompleted
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
University of SydneyTrans Tasman Radiation Oncology GroupUnknownProstate CancerAustralia
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Royal North Shore HospitalCompletedCancer of the ProstateAustralia
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
Centers for Disease Control and PreventionThe University of Texas Health Science Center, HoustonCompletedProstate CancerUnited States
-
Medical University of South CarolinaTerminatedProstate CancerUnited States
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Australian and New Zealand Urogenital and Prostate...Endocyte; Movember Foundation; Australian Nuclear Science and Technology Organisation... and other collaboratorsCompletedMetastatic Cancer | Cancer of the ProstateAustralia
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
SanofiTerminated
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
M.D. Anderson Cancer CenterUnknownProstate CancerUnited States
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Macquarie University, AustraliaUnknown
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Telix Pharmaceuticals (Innovations) Pty LtdRecruitingMetastatic Prostate CancerAustralia, New Zealand
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Ferring PharmaceuticalsCompletedProstate CancerNetherlands, Belgium, Germany, Russian Federation, South Africa, Hungary, Romania, Poland